UR-2922
UR-2922 is an oral antagonist of platelet GPIIb/IIIa. UR-2922 possessed a high affinity for the human platelet receptor (K(d) <1 nM) and a slow dissociation rate (k(off)= 90 min) in vitro. UR-2922 induced no ligand-induced binding sites (LIBS) expression or prothrombotic activity in human platelets.
| Catalog Number | T29073 |
| Alternative Name(s) | UR 2922 |
| Molecular Formula | C25H25N7O6 |
| CAS# | 220386-56-1 |
| SMILES | C([C@H](CC1=CC=C(N(=O)=O)C=C1)NC(=O)C2=CC=C(C(=N)N)C=C2)(=O)N3CC=4C(=NN(CC(O)=O)C4)CC3 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/UR-2922 |
| Additional Information | https://www.targetmol.com/datasheet/T29073 |